| EDUCATIONAL FORUM |
|
| Year : 2006 | Volume
: 38
| Issue : 6 | Page : 383-389 |
Frontline defense against the next pandemic: Antivirals for avian flu
Sohil A Khan1, Padma G M Rao1, P Kumar2, G Rodrigues3
1 Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal-576 104, India
2 Department of Burns and Plastic Surgery, Kasturba Medical College, Manipal-576 104, India
3 Department of Surgery, Kasturba Medical College, Manipal-576 104, India
Correspondence Address:
Sohil A Khan
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal-576 104
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.28203
A pandemic of the human influenza virus has caused extensive morbidity and mortality around the world. The mechanisms involved in the emergence of new influenza viral strains and the epidemiological factors leading to pandemics are unpredictable. The spread of the virus and the challenges encountered in its management are discussed, along with a review on the antivirals against avian influenza. Till date, neuraminidase inhibitors remain the mainstay of management as they are well tolerated and less likely to promote the development of drug resistance, compared to the conventional adamantanes. Details on the clinical effects of antivirals on the infection, safety profile, status in clinical practice and drug resistance are covered in this paper. Future prospects and research to fight the pandemic are also addressed. An outbreak of this infection in various Asian countries emphasises the need for a collaborative approach from healthcare experts, governments and media, to control and curb the spread of infection worldwide.
[FULL TEXT] [PDF]*
|
